Morgan Stanley’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Morgan Stanley’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-27,088	Closed	-$687K	–	6892
2019 Q1	$687K	Sell	27,088 -266,369	-91%	-$4.71M	﹤0.01%	4356
2018 Q4	$3.38M	Buy	293,457 +269,742	+1,137%	+$3.59M	﹤0.01%	3318
2018 Q3	$484K	Buy	23,715 +23,492	+10,535%	+$482K	﹤0.01%	5027
2018 Q2	$4K	Buy	+223	New	+$3.18K	﹤0.01%	6490

Morgan Stanley's NITE Position: Q2 2019 in Review

Morgan Stanley sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 27,088 shares — an estimated $687K sold.

Morgan Stanley first reported a position in NITE in Q2 2018 and held it in 4 quarters. The position peaked at $3.38M in Q4 2018. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Morgan Stanley reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Morgan Stanley sold 27,088 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $687K.
Morgan Stanley first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q2 2018 and held it in 4 quarters.
Morgan Stanley's Nightstar Therapeutics plc American Depositary Shares position peaked at $3.38M in Q4 2018.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.